TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 8388007

Group type: EXPERIMENTAL
Intervention: Nedocromil sodium (1%) administered four times daily
Number of subjects: 104

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 104
Study: 3440393

Group type: EXPERIMENTAL
Intervention: Partial ileal bypass (PIB) surgery
Number of subjects: 838

Group type: COMPARATOR
Intervention: Control group (no surgery)
Number of subjects: 838
Study: 29603219

Group type: EXPERIMENTAL
Intervention: Cognitive-behavior therapy (CBT)
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: Child-centered therapy (CCT)
Number of subjects: 130

Group type: COMPARATOR
Intervention: Healthy control (HC)
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: Post-task ratings
Number of subjects: 130
Study: 28927227

Group type: EXPERIMENTAL
Intervention: Surotomycin 250 mg twice daily
Number of subjects: 26

Group type: COMPARATOR
Intervention: Vancomycin 125 mg four times daily
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Surotomycin 125 mg twice daily
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Surotomycin
Number of subjects: 26
Study: 26182759

Group type: EXPERIMENTAL
Intervention: 1.5% glycine
Number of subjects: 170

Group type: COMPARATOR
Intervention: Sterile distilled water
Number of subjects: 170
Study: 23108780

Group type: EXPERIMENTAL
Intervention: Strontium ranelate (SrRan)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 20577144

Group type: EXPERIMENTAL
Intervention: Probiotics
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Selective decontamination of the digestive tract (SDD)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Standard treatment
Number of subjects: 30
Study: 18335728

Group type: EXPERIMENTAL
Intervention: 35% Hydrogen Peroxide (HP)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: 35% HP plus Halogen Curing Light XL 3000 (3M/ESPE)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: 35% HP plus Demetron LED (Kerr)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: 35% HP plus LED/LASER (Bio-art)
Number of subjects: 40
Study: 16572429

Group type: EXPERIMENTAL
Intervention: Remission induction chemotherapy
Number of subjects: 77
Study: 15272943

Group type: EXPERIMENTAL
Intervention: Compensation for inconsistent behavior of a target by altering attributions of a fellow group member
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Compensation via a fellow group member for a target's inconsistent action
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Tests of capability and motivation assumptions of schema-maintenance through compensation
Number of subjects: 6
Study: 10871578

Group type: EXPERIMENTAL
Intervention: Standard parenteral nutrition (PN) containing conventional amounts of dextrose, amino acids, micronutrients, and lipid (120 kJ/d)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Parenteral nutrition containing only micronutrients and a small amount of lipid (12 kJ/d)
Number of subjects: 24
Study: 9408513

Group type: EXPERIMENTAL
Intervention: Oral angiotensin-converting-enzyme (ACE) inhibitors
Number of subjects: 0
Study: 8257180

Group type: EXPERIMENTAL
Intervention: Recombinant human erythropoietin (r‐HuEpo) administered subcutaneously twice a week
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Recombinant human erythropoietin (r‐HuEpo)
Number of subjects: 11
Study: 3954551

Group type: EXPERIMENTAL
Intervention: Ad lib smoking for two days
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: First four days of abstinence from smoking
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Withdrawal discomfort
Number of subjects: 50
Study: 31300978

Group type: EXPERIMENTAL
Intervention: Child sexual abuse severity
Number of subjects: 739

Group type: EXPERIMENTAL
Intervention: Self-silencing
Number of subjects: 739

Group type: EXPERIMENTAL
Intervention: Divided self
Number of subjects: 739

Group type: EXPERIMENTAL
Intervention: Self-silencing strategies in romantic relationships
Number of subjects: 739
Study: 29278339

Group type: EXPERIMENTAL
Intervention: Pain Visual Analog Scale (VAS)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Tender Joint Count in 28 joints (TJC28)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Pain Visual Analog Scale (VAS) and Swollen Joint Count in 28 joints (SJC28)/Tender Joint Count in 28 joints (TJC28)
Number of subjects: 0
Study: 27075705

Group type: EXPERIMENTAL
Intervention: CDP/BPO (clindamycin 1%/benzoyl peroxide 5%) once daily gel
Number of subjects: 1020

Group type: COMPARATOR
Intervention: CDP (clindamycin 1%) twice daily gel
Number of subjects: 1020
Study: 25566615

Group type: EXPERIMENTAL
Intervention: Kuntai Capsule (KC) combined with gonadotropin-releasing hormone agonist (GnRH-a)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Gonadotropin-releasing hormone agonist (GnRH-a) alone
Number of subjects: 100
Study: 23055493

Group type: EXPERIMENTAL
Intervention: Exposure to low-irradiance intermittent green light (543 nm; 0.1-4 Hz) for 30 min
Number of subjects: 25

Group type: COMPARATOR
Intervention: Continuous low-irradiance light exposure
Number of subjects: 25

Group type: COMPARATOR
Intervention: Absence of rod-cone function
Number of subjects: 25
Study: 20716302

Group type: EXPERIMENTAL
Intervention: Varenicline (2 mg)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 31
Study: 17978058

Group type: EXPERIMENTAL
Intervention: Artesunate plus sulfadoxine/pyrimethamine (As + SP)
Number of subjects: 212

Group type: EXPERIMENTAL
Intervention: Artesunate plus sulfamethoxypyrazine/pyrimethamine (As + SMP)
Number of subjects: 212
Study: 15890352

Group type: EXPERIMENTAL
Intervention: Moving the standard comparison tone before the target tone
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: Using three target comparison tone pairs
Number of subjects: 4

Group type: COMPARATOR
Intervention: Two-interval, forced-choice procedure
Number of subjects: 4
Study: 12236457

Group type: EXPERIMENTAL
Intervention: Relapse prevention (RP)
Number of subjects: 132

Group type: COMPARATOR
Intervention: Standard 12-step focused group continuing care
Number of subjects: 132

Group type: EXPERIMENTAL
Intervention: Relapse prevention (RP) with current depressive disorder at baseline
Number of subjects: 132
Study: 9840564

Group type: EXPERIMENTAL
Intervention: Single-dose intramuscular methotrexate (1 mg/kg)
Number of subjects: 75

Group type: COMPARATOR
Intervention: Laparoscopic salpingostomy
Number of subjects: 75
Study: 7985624

Group type: EXPERIMENTAL
Intervention: Self-reported energy intake calculated from 3-day food records
Number of subjects: 269

Group type: EXPERIMENTAL
Intervention: Men
Number of subjects: 269

Group type: EXPERIMENTAL
Intervention: Women
Number of subjects: 269

Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 269
Study: 2687467

Group type: EXPERIMENTAL
Intervention: Corrugated silastic drain (Portex) placed next to the colonic anastomosis
Number of subjects: 106

Group type: COMPARATOR
Intervention: No drain
Number of subjects: 106
Study: 30670529

Group type: EXPERIMENTAL
Intervention: Tibiotalocalcaneal (TTC) nailing
Number of subjects: 110

Group type: COMPARATOR
Intervention: Open reduction and internal fixation (ORIF)
Number of subjects: 110
Study: 28671626

Group type: EXPERIMENTAL
Intervention: Hypoxia + Carbohydrate (200 mL/20 min maltodextrin)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Hypoxia + Glutamine (20 g/day) and 8% maltodextrin (200 mL/20 min)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Hypoxia placebo
Number of subjects: 15
Study: 26919755

Group type: COMPARATOR
Intervention: Control arm of the trial (specific intervention details not available)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Previous pregnancy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Early and consistent use of antenatal care
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Syphilis test
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Abdominal examination
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Pregnancy danger signs advice
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Skilled birth attendant
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Normal labour duration
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Gestation period of at least 9 months
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Normal delivery
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Blood test for mothers
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Mothers aged less than 16 years and greater than 40 years
Number of subjects: 0
Study: 24491065

Group type: EXPERIMENTAL
Intervention: Physical fitness training (supported or unsupported treadmill training; cardiovascular active aerobic training; five times per week, over 4 weeks; each session 50 minutes; total of 20 sessions) in addition to standard rehabilitation treatment
Number of subjects: 215

Group type: COMPARATOR
Intervention: Relaxation sessions (non-cardiovascular active; five times per week, over 4 weeks; each session 50 minutes) in addition to standard rehabilitation treatment
Number of subjects: 215
Study: 22958784

Group type: EXPERIMENTAL
Intervention: Arthroscopy (ASK)
Number of subjects: 242

Group type: EXPERIMENTAL
Intervention: Musculoskeletal ultrasound (MSUS)
Number of subjects: 242

Group type: COMPARATOR
Intervention: Control group (CON)
Number of subjects: 242

Group type: EXPERIMENTAL
Intervention: All groups (ASK, MSUS, CON)
Number of subjects: 242

Group type: EXPERIMENTAL
Intervention: Arthroscopy tutorial
Number of subjects: 242
Study: 20670963

Group type: EXPERIMENTAL
Intervention: Disease Management Programme (DMP)
Number of subjects: 412

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 412
Study: 17327537

Group type: EXPERIMENTAL
Intervention: Caregiver assessments of patient-centered, family-focused care (PCFFC)
Number of subjects: 210

Group type: EXPERIMENTAL
Intervention: Objective burden
Number of subjects: 210
Study: 16355295

Group type: EXPERIMENTAL
Intervention: Tramadol 100 mg IM
Number of subjects: 40

Group type: COMPARATOR
Intervention: Diclofenac sodium 75 mg IM
Number of subjects: 40
Study: 12029003

Group type: EXPERIMENTAL
Intervention: Atorvastatin (40 mg/day)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Fish oil (4 g/day)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Atorvastatin plus fish oil
Number of subjects: 48

Group type: COMPARATOR
Intervention: Matching placebo
Number of subjects: 48
Study: 9926052

Group type: EXPERIMENTAL
Intervention: Intensive sector services (PACE and PACT teams)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard sector services (generic community team)
Number of subjects: 0
Study: 10512260

Group type: EXPERIMENTAL
Intervention: 12.5 microg IT sufentanil
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: 15 microg IT sufentanil
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: 17.5 microg IT sufentanil
Number of subjects: 60

Group type: COMPARATOR
Intervention: 20 microg IT sufentanil
Number of subjects: 60
Study: 1653313

Group type: EXPERIMENTAL
Intervention: 1:200,000 epinephrine-containing anesthetic solution
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: 4% articaine hydrochloride solution
Number of subjects: 160
Study: 6885206

Group type: EXPERIMENTAL
Intervention: Flurbiprofen
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Flurbiprofen plus frusemide
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Frusemide
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 30522143

Group type: EXPERIMENTAL
Intervention: 370 mg of standardized Epimedium prenylflavonoid extract
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: 740 mg of standardized Epimedium prenylflavonoid extract
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: 1110 mg of standardized Epimedium prenylflavonoid extract
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Standardized Epimedium prenylflavonoid extract
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 27631895

Group type: EXPERIMENTAL
Intervention: Pause procedure (1-min pause at the middle and end of the presentation)
Number of subjects: 214

Group type: COMPARATOR
Intervention: Traditional lecture (control group)
Number of subjects: 214
Study: 26660859

Group type: EXPERIMENTAL
Intervention: 40 IU of intranasal oxytocin
Number of subjects: 13

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 13
Study: 26518980

Group type: EXPERIMENTAL
Intervention: SocketKAP(™) + Anorganic Bovine Bone Mineral (ABBM)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: SocketKAP(™) + SocketKAGE(™) + ABBM
Number of subjects: 36

Group type: COMPARATOR
Intervention: Negative Control (Intact Socket)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Negative Control (Facial Dehiscence Socket)
Number of subjects: 36
Study: 22204857

Group type: EXPERIMENTAL
Intervention: Rosuvastatin 10mg
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Pravastatin 40mg
Number of subjects: 54
Study: 21441615

Group type: EXPERIMENTAL
Intervention: Co-treatment with valproate
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: High level of acridine (33 μM)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Acridine
Number of subjects: 24
Study: 18636543

Group type: EXPERIMENTAL
Intervention: Higher-volume preload (500 ml/171 kcal)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Lower-volume preload (250 ml/171 kcal)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Binge eating disorder participants
Number of subjects: 30

Group type: COMPARATOR
Intervention: Healthy control participants
Number of subjects: 30
Study: 16318999

Group type: EXPERIMENTAL
Intervention: GSTM1 genotype in ICVD group
Number of subjects: 142

Group type: EXPERIMENTAL
Intervention: GSTT1 genotype in ICVD group
Number of subjects: 142

Group type: EXPERIMENTAL
Intervention: Combined analysis for GSTM1 and GSTT1 genotypes in ICVD for smoking status
Number of subjects: 142
Study: 15146227

Group type: EXPERIMENTAL
Intervention: Cisplatin and cyclophosphamide
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Cisplatin and paclitaxel
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Self-reported peripheral neuropathy and functional status scales
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Functional status scale
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Peripheral neuropathy scale
Number of subjects: 88
Study: 11342902

Group type: EXPERIMENTAL
Intervention: Maintenance therapy with 6 intravesical instillations every 6 months for 2 years
Number of subjects: 131

Group type: COMPARATOR
Intervention: Control group with no maintenance therapy
Number of subjects: 131

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 131
Study: 10480684

Group type: EXPERIMENTAL
Intervention: Family history of colorectal cancer (first degree relative)
Number of subjects: 702

Group type: EXPERIMENTAL
Intervention: Family history of colorectal cancer (more than one family member affected)
Number of subjects: 702

Group type: EXPERIMENTAL
Intervention: Sibling history of colorectal cancer
Number of subjects: 702

Group type: EXPERIMENTAL
Intervention: High parity
Number of subjects: 702

Group type: COMPARATOR
Intervention: Exogenous hormonal factors (hormone replacement therapy)
Number of subjects: 702
Study: 8747798

Group type: EXPERIMENTAL
Intervention: Inhaled histamine (PC20 < or = 8.0 mg/ml)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Exercise (delta % FEV1 < or = 10%)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Inhaled histamine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Exercise
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: BHR to histamine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: BHR to exercise
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Bronchial challenge testing
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: BHR
Number of subjects: 0
Study: 2676258

Group type: EXPERIMENTAL
Intervention: Intervention group (population hypertension control programs)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Reference group (control)
Number of subjects: 0
Study: 354916

Group type: EXPERIMENTAL
Intervention: Mianserin (30 mg or 60 mg)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 31389524

Group type: EXPERIMENTAL
Intervention: Abbreviated fasting
Number of subjects: 33
Study: 28681506

Group type: EXPERIMENTAL
Intervention: GSK2245035 80 ng
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: GSK2245035 20 ng
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: GSK2245035 20 ng and 80 ng
Number of subjects: 42

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 42
Study: 26049675

Group type: EXPERIMENTAL
Intervention: Fresh red blood cell units stored seven days or less
Number of subjects: 2430

Group type: COMPARATOR
Intervention: Control group (standard delivery policy, red blood cell units stored about three weeks)
Number of subjects: 2430
Study: 23778783

Group type: EXPERIMENTAL
Intervention: Moderately high protein diets
Number of subjects: 685

Group type: COMPARATOR
Intervention: Low protein diets
Number of subjects: 685

Group type: EXPERIMENTAL
Intervention: High glycemic index diets
Number of subjects: 685

Group type: EXPERIMENTAL
Intervention: Low glycemic index diets
Number of subjects: 685
Study: 21712619

Group type: EXPERIMENTAL
Intervention: 20 mg of tenoxicam
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: 200 mg of ibuprofen
Number of subjects: 48

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 48
Study: 19944984

Group type: EXPERIMENTAL
Intervention: Plastic stent placement
Number of subjects: 37

Group type: COMPARATOR
Intervention: Nasolacrimal cryoplasty
Number of subjects: 37
Study: 16924340

Group type: EXPERIMENTAL
Intervention: Enforce resin-based cement
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Zinc phosphate cement
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: EndoFill + gutta-percha
Number of subjects: 24

Group type: COMPARATOR
Intervention: Gutta-percha alone (no cement)
Number of subjects: 24
Study: 15322855

Group type: EXPERIMENTAL
Intervention: Inspiratory muscle training (IMT) for 4 weeks
Number of subjects: 18

Group type: COMPARATOR
Intervention: Control group (Con)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Inspiratory muscle training (IMT)
Number of subjects: 18
Study: 11385163

Group type: EXPERIMENTAL
Intervention: Ticlopidine monotherapy (2 x 250 mg daily)
Number of subjects: 243

Group type: COMPARATOR
Intervention: Combined treatment (2 x 250 mg ticlopidine plus 100 mg aspirin daily)
Number of subjects: 243
Study: 9435797

Group type: EXPERIMENTAL
Intervention: Physiotherapy alone
Number of subjects: 257

Group type: COMPARATOR
Intervention: Shoulder movement alone
Number of subjects: 257

Group type: EXPERIMENTAL
Intervention: Both physiotherapy and shoulder movement
Number of subjects: 257

Group type: COMPARATOR
Intervention: Neither physiotherapy nor shoulder movement
Number of subjects: 257

Group type: EXPERIMENTAL
Intervention: Shoulder movement (in both physiotherapy and shoulder movement groups)
Number of subjects: 257
Study: 9617710

Group type: EXPERIMENTAL
Intervention: Non-radioactive polymerase chain reaction (PCR) procedure to detect (CTG)n repeat expansion in DM patients
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Non-radioactive PCR for prenatal diagnosis in pregnant DM mothers
Number of subjects: 24
Study: 2493366

Group type: EXPERIMENTAL
Intervention: Misoprostol (200 micrograms)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Indomethacin (75 mg, at -8 hr; 50 mg, -1 hr)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Coadministration of Misoprostol and Indomethacin
Number of subjects: 12
Study: 772665

Group type: EXPERIMENTAL
Intervention: Oral antigen (1 ml a day for four weeks)
Number of subjects: 110

Group type: COMPARATOR
Intervention: Placebo (1 ml a day for four weeks)
Number of subjects: 110
Study: 31992217

Group type: EXPERIMENTAL
Intervention: Smartphone-based videoconferencing program (using LINE app), once a week for 6 months.
Number of subjects: 62

Group type: COMPARATOR
Intervention: Control group (no smartphone-based videoconferencing program).
Number of subjects: 62
Study: 30102874

Group type: EXPERIMENTAL
Intervention: Caffeine (5 mg/kg)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 28800182

Group type: EXPERIMENTAL
Intervention: TIME‐TQ intervention
Number of subjects: 35
Study: 25924711

Group type: EXPERIMENTAL
Intervention: Supervised, intensive resistance exercise program (1 year)
Number of subjects: 148

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 148
Study: 23512818

Group type: EXPERIMENTAL
Intervention: Aerobic Exercise (AE)
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Resistance Exercise (RE)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Control
Number of subjects: 39
Study: 21615623

Group type: EXPERIMENTAL
Intervention: Mosapride 15 mg
Number of subjects: 37

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 37
Study: 18805583

Group type: EXPERIMENTAL
Intervention: Oral valganciclovir (900 mg twice daily)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Intravenous ganciclovir (5 mg/kg twice daily)
Number of subjects: 27
Study: 17020428

Group type: EXPERIMENTAL
Intervention: Proton-pump inhibitor therapy
Number of subjects: 0
Study: 15288916

Group type: EXPERIMENTAL
Intervention: Self-administered QLQ-SAT32
Number of subjects: 123

Group type: COMPARATOR
Intervention: Interview-administered QLQ-SAT32
Number of subjects: 123
Study: 11704591

Group type: EXPERIMENTAL
Intervention: Ibuprofen treatment in CF subjects
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: No ibuprofen treatment in CF subjects
Number of subjects: 14

Group type: COMPARATOR
Intervention: Control subjects
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Exercise in both CF and control subjects
Number of subjects: 14
Study: 9415633

Group type: EXPERIMENTAL
Intervention: Sodium fluoride (40 mg/day)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 38
Study: 8302450

Group type: EXPERIMENTAL
Intervention: PCA (infusor Baxter) with morphine i.v. (basal bolus 0.05 mg/kg, loading doses 1 mg every 6‐15')
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: PCA (morphine i.v., basal bolus 0.07 mg/kg, bolus PCA 0.007 mg/kg lock‐out 15')
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: PCA
Number of subjects: 84
Study: 3518333

Group type: EXPERIMENTAL
Intervention: Lignocaine nasal spray
Number of subjects: 25

Group type: COMPARATOR
Intervention: Saline nasal spray (Control)
Number of subjects: 25
Study: 31358329

Group type: EXPERIMENTAL
Intervention: Levosimendan
Number of subjects: 848

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 848
Study: 29763783

Group type: EXPERIMENTAL
Intervention: Citalopram (2 mg/unit BMI)
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: Dexamethasone (1.5 mg)/Corticotropin-releasing factor (1 μg/kg)
Number of subjects: 82